Perspectives on using Physcomitrella patens as an alternative production platform for thapsigargin and other terpenoid drug candidates

Perspectives in Medicinal Chemistry

Volumn 2009, Issue 3, 2009, Pages 1-6

  Simonsen, Henrik Toft ^a   Drew, Damian Paul ^a   Lunde, Christina ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Drug production; Physcomitrella; Sesquiterpene; Thapsigargin

Indexed keywords

ARTEMISININ; ERYTHROPOIETIN; PARTHENOLIDE; TERPENOID DERIVATIVE; THAPSIGARGIN;

ARTICLE; BIOTECHNOLOGY; CALLUS CULTURE; CHIRALITY; COMBINATORIAL CHEMISTRY; DRUG INDUSTRY; DRUG SYNTHESIS; MICROPROPAGATION; NONHUMAN; PHYSCOMITRELLA; PHYSCOMITRELLA PATENS; PLANT METABOLISM; SIGNAL TRANSDUCTION; TANACETUM PARTHENIUM;

EID: 73649104921     PISSN: None     EISSN: 1177391X     Source Type: Journal    
DOI: 10.4137/pmc.s2220     Document Type: Article

References (51)

1. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007;70:461-77.
2. Chang MCY, Keasling JD. Production of isoprenoid pharmaceuticals by engineered microbes. Nat Chem Biol. 2006;2:674-81.
3. Barton Sir D, Nakanishi K, Meth-Cohn O. Comprehensive natural products chemistry. Elsevier Science Ltd, London. 1999.
4. Modzelewska A, Sur S, Kumar SK, Khan SR. Sesquiterpenes: Natural products that decrease cancer growth. Curr Med Chem-Anti-Cancer Agents. 2005;5:477-99.
5. Evans WC. Trease and Evans' pharmacognosy, 13 ed., London, U.K.: Bailliere Tindal. 1989.
6. Simonsen HT, Larsen MD, Nielsen MW, et al. Methylenedioxy- and methoxyflavones from Melicope coodeana syn. Euodia simplex. Phytochem. 2002;60:817-20.
7. Simonsen HT, Nordskjold JB, Smitt UW, et al. In vitro screening of Indian medicinal plants for antiplasmodial activity. J. Ethnopharm. 2001;74:195-204.
8. Rocha ABD, Lopes RM, Schwartsmann G. Natural products in anticancer therapy. Curr Opin Pharmacol. 2001;1:364-9.
9. Gordon M Cragg, David J Newman. Plants as a source of anti-cancer agents. Journal of Ethnopharmacology. 22 August 2005;100(1-2): 72-79.
10. Withers ST, Keasling JD. Biosynthesis and engineering of isoprenoid small molecules. Appl Microbiol Biotechn. 2007;73:980-90.
11. Withers. Source of New Hope Against Malaria is in Short Supply Martin Enserink Science 7 January 2005;307(5706):33.
12. Phyton Biotech. History. Product information [online]. Acccesed on 18 December 2008. URL: http://www.phytonbiotech.com/. 2008.
13. Makunga NP, Jäger AK, Van Staden J. Micropropagation of Thapsia garganica - a medicinal plant. Plant Cell Rep. 2003;21:967-73.
14. Denmeade SR, Jakobsen CM, Janssen S. Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer. J Natl Cancer Inst. 2003;95:990-1000.
15. Janssen S, Rosen DM, Ricklis RM, et al. Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug. The Prostate. 2006;66:358-68.
16. Søhoel H, Jensen AM, Moller JV, et al. Natural products as starting materials for development of second-generation SERCA inhibitors targeted towards prostate cancer cells. Bioorg Med Chem. 2006; 14:2810-15.
17. Toyoshima C, Nomura H. Structural changes in the calcium pump accompanying the dissociation of calcium. Nature. 2002;418:605-11.
18. Ekiert H. Medicinal plant biotechnology: the Apiaceae family as an example of development. Pharmazie. 2000;55:561-67.
19. Jäger AK, Schottländer B, Smitt UW, et al. Somatic embryogenesis in cell cultures of Thapsia garganica: Correlation between the state of differentiation and the content of thapsigargins. Plant Cell Rep. 1993;12:517-20.
20. Makunga NP, Jäger AK, Van Staden J. Improved in vitro rooting and hyperhydricity in regenerating tissues of Thapsia garganica L. Plant Cell Tiss Organ Cult. 2006;86:77-86.
21. Ebrahimie E, Habashi AA, Ghareyazie B, et al. A rapid and efficient method for regeneration of plantlets from embryo explants of cumin (Cuminum cyminum). Plant Cell Tiss Org Cult. 2003;75:19-25.
22. Ball M, Andrews SP, Wierschem F, et al. Total synthesis of thapsigargin, a potent SERCA pump inhibitor. Org Lett. 2007;9:663-6.
23. Kirby J, Keasling JD. Metabolic engineering of microorganisms for isoprenoid production. Nat Prod Rep. 2008;25:656-61.
24. Chang MC, Eachus RA, Trieu W, et al. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol. 2007;3:274-277.
25. Simonsen HT, Reichwald K, Krichau N (in press). Guaianolides in Apiaceae, perspectives on pharmacology and biosynthesis. Phytochem Rev.
26. Paradise EM, Kirby J, Chan R, et al. Redirection of flux through the FPP branch-point in Saccharomyces cerevisiae by down-regulating squalene synthase. Biotech Bioeng. 2008;100:371-78.
27. Aharoni A, Jongsma MA, Kim T-Y, et al. Metabolic engineering of terpenoid biosynthesis in plants. Phytochem Rev. 2006;5:49-58.
28. Besumbes O, Sauret-Gueto S, Phillips MA, et al. Metabolic engineering of isoprenoid biosynthesis in Arabidopsis for the production of taxadiene, the first committed precursor of taxol. Biotechnol Bioeng. 2004;88:168-75.
29. Reski R. Do we need another model plant? Plant Biol. 2005;7:219.
30. Reski R. Development, genetics and molecular biology of mosses. Botanica Acta. 1998;111:1-15.
31. Decker EL, Reski R. Moss bioreactors producing improved biopharmaceuticals. Curr opin Plant Biotech. 2007;18:393-98.
32. Decker EL, Reski R. Current achievements in the production of complex biopharmaceuticals with moss bioreactors. Bioprocess Biosyst Eng. 2008;31:3-9.
33. Weise A, Altmann F, Rodriguez-Franco M, et al. High-level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella Delta-fuc-t Delta-xyl-t mutant. Plant Biotech J. 2007;5:389-401.
34. Huether CM, Lienhart O, Baur A, et al. Glyco-engineering of moss lacking plant-specific sugar residues. Plant Biol. 2005;7:292-9.
35. Ashton NW, Cove DJ. Isolation and preliminary characterization of auxotrophic and analog resistant mutants of moss, Physcomitella patens. Mol Gen Genet. 1977;154:87-95.
36. Greenovation. Research information, production information [online]. Accessed 18 December 2008. URL: http://www.greenovation.de/. 2008.
37. Frank W, Ratnadewi D, Reski R. Physcomitrella patens is highly tolerant against drought, salt and osmotic stress. Planta. 2005a; 220:384-94.
38. Schaefer DG. A new moss genetics: Targeted mutagenesis in Physcomitrella patens. Annu Rev Plant Biol. 2002;53:477-501.
39. Frank W, Decker EL, Reski R. Molecular tools to study Physcomitrella patens. Plant Biol. 2005b;7:220-7.
40. Horstmann V, Huether CM, Jost W, et al. Quantitative promoter analysis in Physcomitrella patens: a set of plant vectors activating gene expression within three orders of magnitude. BMC Biotech. 2004;4:13.
41. Saidi Y, Finka A, Chakhporanian M, et al. Controlled expression of recombinant proteins in Physcomitrella patens by a conditional heatshock promoter: A tool for plant research and biotechnology. Plant Mol Biol. 2005;59:697-711.
42. + via sodium ATPase (PpENA1) ensures normal growth of Physcomitrella patens under moderate salt stress. Plant Phys. 2007;144:1786-96.
43. Schwartzenberg von K, Schultze W, Kassner H. The moss Physcomitrella patens releases a tetracyclic diterpene. Plant Cell Rep. 2004;22:780-6.
44. Hayashia K-I, Kawaideb H, Notomib M, et al. Identification and functional analysis of bifunctional ent-kaurene synthase from the moss Physcomitrella patens. FEBS Lett. 2006;580:6175-81.
45. Weissman KJ, Leadlay PF. Combinatorial biosynthesis of reduced polyketides. Nature Rev Microbio. 2005;3:925-36.
46. Piel J. Combinatorial biosynthesis in symbiotic bacteria. Nat Chem Biol. 2006;2:661-2.
47. Guzman ML, Rossi RM, Karnischky L, et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood. 2005;105:4163-9.
48. Ernst E, Pittler MH. The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review. Public Health Nutr. 2000;3:509-14.
49. De Kraker JW, Franssen MCR, de Groot A, et al. (+)-Germacrene A biosynthesis - The committed step in the biosynthesis of bitter sesquiterpene lactones in chicory. Plant Physiol. 1998; 117:1381-92.
50. De Kraker JW, Franssen MCR, Joerink M, et al. Biosynthesis of costunolide, dihydrocostunolide, and leucodin. Demonstration of cytochrome P450-catalyzed formation of the lactone ring present in sesquiterpene lactones of chicory. Plant Physiol. 2002;129:257-68.
51. Okada K, Kasahara H, Yamaguchi S, et al. Genetic evidence for the role of isopentenyl diphosphate isomerases in the mevalonate pathway and plant development in Arabidopsis. Plant Cell Phys. 2008; 49:604-16.